tetradecanoylphorbol acetate has been researched along with cardiovascular agents in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, H; Gabazza, EC; Suzuki, K; Takeya, H; Urano, H; Zhou, H | 1 |
| Fyhrquist, F; Nyman, T; Saijonmaa, O | 1 |
| Benéteau, N; Chapuis, V; Colpaert, FC; Dupont-Passelaigue, E; Junquéro, D; Lestienne, F; Patoiseau, JF; Rival, Y; Taillandier, T | 1 |
| Beck-Oldach, K; Horowitz, JD; Kennedy, JA; McFadden-Lewis, K; Murphy, GA; Wong, YW; Zhang, Y | 1 |
4 other study(ies) available for tetradecanoylphorbol acetate and cardiovascular agents
| Article | Year |
|---|---|
Adenosine regulates tissue factor expression on endothelial cells.
Topics: Adenosine; Cardiovascular Agents; Cells, Cultured; Endothelium, Vascular; Hemostatics; Humans; Infant, Newborn; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Tetradecanoylphorbol Acetate; Thrombin; Thromboplastin; Tumor Necrosis Factor-alpha; Umbilical Veins; Xanthines | 1998 |
Carvedilol inhibits basal and stimulated ACE production in human endothelial cells.
Topics: Carbazoles; Cardiovascular Agents; Carvedilol; Cells, Cultured; Endothelium, Vascular; Humans; Immunoblotting; Peptidyl-Dipeptidase A; Phosphorylation; Propanolamines; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Umbilical Veins; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2004 |
Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
Topics: Acetamides; Acetates; Anilides; Cardiovascular Agents; Cell Line; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins, LDL; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mevalonic Acid; Monocytes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tetradecanoylphorbol Acetate; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors | 2004 |
Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation.
Topics: Angina Pectoris; Animals; Animals, Newborn; Aorta, Thoracic; Aortic Valve; Cardiovascular Agents; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Free Radical Scavengers; Humans; In Vitro Techniques; Luminescent Measurements; Male; N-Formylmethionine Leucyl-Phenylalanine; NADP; NADPH Oxidases; Neutrophils; Perhexiline; Rats; Rats, Wistar; Superoxides; Swine; Tetradecanoylphorbol Acetate | 2006 |